A new important intelligence tool called Daily Updates: Breaking Publications for the Drug Development Sector.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c37707) has announced the addition of Daily Updates: Breaking Publications for the Drug Development Sector to their offering. DailyUpdates for R&D Personnel - If your job depends on keeping up to date with breaking research articles and drug development news then you will be using one of the many keyword-based database search tools. - Keywords can probably identify a few hundred new journal articles and press releases relevant to your area of interest from the thousands that appear each week. But do you have the time to scan your short-list for information that is key to drug discovery and development? - In 2002 the drug development consultants, launched DailyUpdates. Using the R&D expertise the authors regularly scan PubMed and various press release services for breaking information that is key to the drug development sector. Selected information is then delivered to 1,000's of individuals plus many of the top 20 pharmaceutical companies through 7 different e-mail channels each dedicated to a different therapeutic area. DailyUpdates has emerged as a key tool used by to track key events in the drug discovery sector. DailyUpdates for Authors - DailyUpdates not only represent an important intelligence tool for R&D personnel, it is also a showcase for important research. As well as using DailyUpdates to track breaking information you may also wish to submit research to be listed. If you have recently published you can request listing through our submission center; if your paper meets our inclusion criteria we will be happy to list it. This is good for us because it helps us provide key information to our audience; just as importantly it is good for you if you are looking for exposure in order to attract licensing opportunities or simply recognition for your organization. What DailyUpdates offers - Breaking information key to preclinical & clinical development. DailyUpdates' panel of industry experts selects key information as it appears in the scientific literature or in press releases. Especial importance is placed on research & news items describing novel molecular targets; proof of concept data supporting emerging therapeutic areas; clinical activity of developmental drugs and; regulatory affairs - Drug development news: Breaking news is selected from the major press release services such as PRWire & Business Wire. Drug development, clinical trial, and regulatory affairs releases are all listed and linked through to the full press release. - Cutting edge journal articles: Proprietary search technology is used to scan PubMed on a regular basis. Our panel of industry experts then selects, from this short-list, articles judged to be of especial importance to drug development. All content is linked to publishers abstracts; depending on institutional licenses readers can also access full text articles - DailyUpdates, A showcase for breaking research: Research featured by DailyUpdates gains extensive exposure. This is good for us since our initial aim was to establish an environment that helps optimize drug development. We also believe that high quality research deserves recognition and perhaps more importantly, exposure through DailyUpdates is therefore also good for authors and their organizations since this provides a showcase for key studies. This exposure has the added benefit of encouraging industrial funding and licensing where relevant. Authors wishing to have a paper listed should visit our submission center - Editorial Comment: the editors provide information ranging from scientific background for more basic research content to mechanism of action, drug development news and market size for content relating to developmental candidates. - Choice of therapeutic focus: DailyUpdates is focused on drug development. The focus is increased still further by providing 7 "channels" of DailyUpdates each focusing on a different core area For more information visit http://www.researchandmarkets.com/reports/c37707 |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion